These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35576922)

  • 1. First application of the BIANCA biophysical model to carbon-ion patient cases.
    Kozłowska WS; Carante MP; Aricò G; Embriaco A; Ferrari A; Magro G; Mairani A; Ramos R; Sala P; Georg D; Ballarini F
    Phys Med Biol; 2022 May; 67(11):. PubMed ID: 35576922
    [No Abstract]   [Full Text] [Related]  

  • 2. In Vivo Validation of the BIANCA Biophysical Model: Benchmarking against Rat Spinal Cord RBE Data.
    Carante MP; Aricò G; Ferrari A; Karger CP; Kozlowska W; Mairani A; Sala P; Ballarini F
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthy Tissue Damage Following Cancer Ion Therapy: A Radiobiological Database Predicting Lymphocyte Chromosome Aberrations Based on the BIANCA Biophysical Model.
    Embriaco A; Ramos R; Carante M; Ferrari A; Sala P; Vercesi V; Ballarini F
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiobiological damage by space radiation: extension of the BIANCA model to heavy ions up to iron, and pilot application to cosmic ray exposure.
    Ramos RL; Embriaco A; Carante MP; Ferrari A; Sala P; Vercesi V; Ballarini F
    J Radiol Prot; 2022 May; 42(2):. PubMed ID: 35453133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity of radiobiological models in carbon ion radiotherapy (CIRT) and its consequences on the clinical treatment plan: Differences between LEM and MKM models.
    Góra J; Grosshagauer S; Fossati P; Mumot M; Stock M; Schafasand M; Carlino A
    J Appl Clin Med Phys; 2024 Jul; 25(7):e14321. PubMed ID: 38436509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First benchmarking of the BIANCA model for cell survival prediction in a clinical hadron therapy scenario.
    Carante MP; Aricò G; Ferrari A; Kozlowska W; Mairani A; Ballarini F
    Phys Med Biol; 2019 Oct; 64(21):215008. PubMed ID: 31569085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of potential advantages of relevant ions for particle therapy: a model based study.
    Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
    Med Phys; 2015 Feb; 42(2):1037-47. PubMed ID: 25652516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
    Gillmann C; Jäkel O; Schlampp I; Karger CP
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical note: Impact of beamline-specific particle energy spectra on clinical plans in carbon ion beam therapy.
    Resch AF; Schafasand M; Lackner N; Niessen T; Beck S; Elia A; Boersma D; Grevillot L; Fossati P; Glimelius L; Stock M; Georg D; Carlino A
    Med Phys; 2022 Jun; 49(6):4092-4098. PubMed ID: 35416302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling secondary cancer risk ratios for proton versus carbon ion beam therapy: A comparative study based on the local effect model.
    Hufnagl A; Johansson G; Siegbahn A; Durante M; Friedrich T; Scholz M
    Med Phys; 2022 Aug; 49(8):5589-5603. PubMed ID: 35717591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological effectiveness of He-3 and He-4 ion beams for cancer hadrontherapy: a study based on the BIANCA biophysical model.
    Carante MP; Embriaco A; Aricò G; Ferrari A; Mairani A; Mein S; Ramos R; Sala P; Ballarini F
    Phys Med Biol; 2021 Sep; 66(19):. PubMed ID: 34507306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
    Gillmann C; Jäkel O; Karger CP
    Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
    Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
    Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results.
    Grosshagauer S; Fossati P; Schafasand M; Carlino A; Poljanc K; Radakovits T; Stock M; Hug E; Georg P; Pelak M; Góra J
    Radiother Oncol; 2022 Oct; 175():73-78. PubMed ID: 35952977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/β = 2 Gy overestimates the RBE.
    Eichkorn T; Karger CP; Brons S; Koerber SA; Mielke T; Haberer T; Debus J; Herfarth K
    Radiother Oncol; 2022 Aug; 173():223-230. PubMed ID: 35714806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast Biological Modeling for Voxel-based Heavy Ion Treatment Planning Using the Mechanistic Repair-Misrepair-Fixation Model and Nuclear Fragment Spectra.
    Kamp F; Cabal G; Mairani A; Parodi K; Wilkens JJ; Carlson DJ
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):557-68. PubMed ID: 26460998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Monte Carlo-based treatment-planning tool for ion beam therapy.
    Böhlen TT; Bauer J; Dosanjh M; Ferrari A; Haberer T; Parodi K; Patera V; Mairani A
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i77-81. PubMed ID: 23824131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity study of the microdosimetric kinetic model parameters for carbon ion radiotherapy.
    Dahle TJ; Magro G; Ytre-Hauge KS; Stokkevåg CH; Choi K; Mairani A
    Phys Med Biol; 2018 Nov; 63(22):225016. PubMed ID: 30418940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spot-scanning hadron arc (SHArc) therapy: A proof of concept using single- and multi-ion strategies with helium, carbon, oxygen, and neon ions.
    Mein S; Kopp B; Tessonnier T; Liermann J; Abdollahi A; Debus J; Haberer T; Mairani A
    Med Phys; 2022 Sep; 49(9):6082-6097. PubMed ID: 35717613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of mechanism-inspired models for particle relative biological effectiveness (RBE).
    Stewart RD; Carlson DJ; Butkus MP; Hawkins R; Friedrich T; Scholz M
    Med Phys; 2018 Nov; 45(11):e925-e952. PubMed ID: 30421808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.